# GastrointestinalAgents: Unspecified GI

**LENGTH OF AUTHORIZATIONS**: 365 Days

**PRIOR AUTHORIZATION CRITERIA:**

Is there any reason the patient cannot be changed to a medication not requiring prior approval? Acceptable reasons include:

- Allergy to medications not requiring prior approval

- Contraindication to or drug interaction with medications not requiring prior approval

- History of unacceptable/toxic side effects to medications not requiring prior approval

**STEP THERAPY:**  all agents listed

1.  For a drug requiring step therapy, there must have been inadequate clinical response to preferred alternatives, including no less than a 14-day trial of at least two medications not requiring prior approval
2.  For a non-preferred drug, there must have been inadequate clinical response to preferred alternatives, including no less than 14-day trial of at least three preferred products including one step therapy product

**ADDITIONAL INFORMATION:**

1.  Patient must be 18 years or older
2.  ZORBTIVE and GATTEX require a diagnosis of short bowel syndrome (SBS) and evidence of specialize nutritional support
    1.  GATTEX requires evidence of parenteral nutrition support at least three times per 7 days and appropriate colonoscopy and lab assessment (bilirubin, alkaline phosphatase, lipase, and amylase) 180 days prior to initiation
    2.  Re-authorization of these therapies requires evidence of improved condition (i.e. as measured by total volume, total calories, or decreased frequency of specialized nutrition support)
3.  MYTESI requires a diagnosis of non-infectious diarrhea and evidence of concurrent HIV antiviral therapy
    1.  MYTESI will be limited to no more than 2 tablets per day
4.  RELISTOR and SYMPROIC require a history of chronic pain requiring continuous opioid therapy for 84 days or longer. Electronic PA will approve with a history of 90 days of opioid therapy in the previous 90 days, in addition to trials of preferred products
5.  AEMCOLO initial approval criteria for Travelersâ€™ Diarrhea (TD) (must meet all): a. Diagnosis of TD

    b. Inability to take, or failure of, any of the following:

    o Azithromycin (generic Zithromax) o Ciprofloxacin (generic Cipro) o Levofloxacin (generic Levaquin) o Ofloxacin (generic Floxin) o Xifaxan (rifaximin)

    c. Approval duration is 3 days
